Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

JUL 21, 2014 - Zacks Investment Research

A Must Read - Share

Amgen's AMG 416 Succeeds in Phase III, Shares Up - Analyst Blog

Amgen Inc. (AMGN) announced that AMG 416 (formerly known as velcalcetide) has met the primary as well as secondary endpoints in a phase III study.

Tags: Amgen's AMG 416 Succeeds in Phase III, Shares Up - Analyst Blog,  Amgen Latest News

JUL 17, 2014 - Wall Street Journal

A Must Read - Share

Amgen Hormone Drug Proves Positive in Study

Amgen Inc. said its experimental treatment for secondary hyperparathyroidism in chronic kidney disease showed positive results in a phase III study.

Tags: Amgen Hormone Drug Proves Positive in Study,  Amgen Latest News

JUL 17, 2014 - Benzinga

A Must Read - Share

UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis(

Amgen (NASDAQ: AMGN) today announced that a Phase 3 study evaluating AMG 416 (formerly known as velcalcetide) for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints.

Tags: UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis(,  Amgen Latest News

JUL 11, 2014 - Business Insider

A Must Read - Share

MORGAN STANLEY: Here Are The 15 Best Stocks For The Next 12 Months

Morgan Stanley analysts published their annual "Vintage Values 2015" report highlighting what they considered to be the best stocks for the next 12 months. "We selected stocks with over $1 billion in market cap that look likely to realize superior risk-adjusted returns between now and July 2015," they wrote Their research reflects consideration of anticipated events over the next year, ...

Tags: MORGAN STANLEY: Here Are The 15 Best Stocks For The Next 12 Months,  Amgen Latest News

JUL 03, 2014 - Zacks Investment Research

A Must Read - Share

BIND Therapeutics Ends Oncology Deal with Amgen - Analyst Blog

BIND Therapeutics (BIND) announced the completion of its one and a half year old agreement with Amgen (AMGN).

Tags: BIND Therapeutics Ends Oncology Deal with Amgen - Analyst Blog,  Amgen Latest News